EU regulators pause investigation into Illumina, Grail deal
BRUSSELS, Aug 12 (Reuters) - EU antitrust regulators have temporarily halted their investigation into Illumina Inc's proposed purchase of cancer test maker Grail Inc as they wait for the U.S. life sciences company to provide requested data, an EU filing showed on Thursday.
The European Commission, which had previously set a Nov. 29 deadline for its decision on the deal, will announce a new deadline once it has received the information, in line with its policy.
The EU competition watchdog last month warned that the deal could restrain innovation which could require Illumina to offer concessions to address its concerns.
The $8 billion cash-and-stock deal for startup Grail will see Illumina buy out investors including Amazon founder Jeff Bezos to regain control of a company it spun out five years ago. (Reporting by Foo Yun Chee; Editing by Susan Fenton)
